New Mountain Capital Buying Covidien's Specialty Chemicals Biz

New Mountain Capital has agreed to buy the Specialty Chemicals business of Covidien (NYSE: COV) for $280 million. The Phillipsburg, N.J.-based group makes chemicals under the J.T.Baker and Mallinckrodt Laboratory Chemicals brands.

DealsNorth AmericaUSBriefs